Objective: To assess the effectiveness of intradiscal electrothermal treatment (IDET) combined with epidural steroid injection for discogenic lumbago-leg pain.
Methods: Fifty-nine patients with discogenic lower back pain and radical pain underwent IDET and CT guided spinal cord epidural steroid injection (Limethason). Thirty-eight patients with discogenic lower back pain and radical pain underwent IDET only. The clinical efficacy was observed within 1 week, 1 week-1 month, 1 - 3 months, and 3 - 6 months after the treatment.
Results: The efficacy rates within 1 week, 1 week-1 month, 1 - 3 months, and 3 - 6 months after the treatment of the IDET plus epidural steroid injection group were 71%, 55%, 81%, and 89% respectively, and those of the IDET only group were 55%, 34%, 76% and 87% respectively. The efficacy rate 1 week-1 month postoperatively of the IDET plus epidural steroid injection group was significantly higher than that of the IDET only group (chi(2) = 4.375, P < 0.05), and the efficacy rates at other time points were not significantly different between these 2 groups.
Conclusion: IDET combined with epidural steroid injection relieves post-IDET edema and induces pain more effectively.
Download full-text PDF |
Source |
---|
Skeletal Radiol
January 2025
Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Objective: Transforaminal epidural steroid injection (TFESI) is highly effective in alleviating radicular back pain. While predictive factors for TFESI treatment outcomes have been previously studied, there is a lack of data on the relationship between facet joint degeneration and TFESI efficacy. This study is aimed at studying the impact of facet joint degeneration on TFESI treatment outcomes for unilateral radicular pain.
View Article and Find Full Text PDFAim: The aim of this study is to investigate the effect of obesity on the treatment outcomes of lumbar transforaminal epidural steroid injections (TFESIs).
Material And Methods: This retrospective study included patients who underwent single-level TFESI in a pain management center between January 2021 and April 2023. Body mass index (BMI) of the patients was evaluated based on the World Health Organization guidelines.
Cureus
December 2024
Orthopedic Surgery, King Edward Medical University, Lahore, PAK.
Background Lumbar radicular pain occurs due to irritation or compression of the nerve roots in the lower back. This study aimed to evaluate the efficacy of transforaminal epidural steroid injections (TFESIs) in reducing pain and improving functional outcomes in a diverse patient population with lumbar radicular pain. Methodology This quasi-experimental trial was performed at the Department of Orthopedic Surgery and Traumatology, Unit 1, Mayo Hospital, Lahore, from October 2021 to September 2022.
View Article and Find Full Text PDFIntegr Med (Encinitas)
December 2024
Borandi Acupuncture, Saint George, UT.
Introduction: Chronic low back pain (CLBP), or low back pain lasting greater than 12 weeks, is a prevalent condition that profoundly impacts the quality of life in affected individuals. Traditional treatments - such as physical therapy, medications, injections, minimally invasive procedures, and surgery - often prove ineffective in a considerable number of cases, particularly when utilized as singular modalities. Given the complex biopsychosocial nature of CLBP, a multi-modality approach tailored to each patients' unique needs is essential.
View Article and Find Full Text PDFBackground: The primary objective of this study was to compare the efficacy of lignocaine-dexamethasone and lignocaine-triamcinolone infiltration, along the spinal-epidural needle insertion pathway, to prevent backache after lower abdominal surgeries.
Methods: This prospective, double-blind randomized controlled study included a total of 150 patients, scheduled for elective lower abdominal surgery under combined spinal-epidural (CSE) anaesthesia. The patients were randomised into three groups Group L (Lignocaine, n=50), Group DL (Dexamethasone, Lignocaine, n=50), and Group TL (Triamcinolone, Lignocaine, n=50).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!